Eric J Brandt, Kendrin Sonneville, Matthias Kirch, Tammy Chang
{"title":"Association of Glucagon-Like Peptide Agonist Therapy With Dietary Patterns in a Cross-Sectional Cohort.","authors":"Eric J Brandt, Kendrin Sonneville, Matthias Kirch, Tammy Chang","doi":"10.1002/osp4.70079","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mechanisms by which glucagon-like peptide receptor agonists (GLPRAs) improve cardiovascular outcomes remain incompletely understood. Whether taking GLPRAs are associated with differential dietary patterns remains unknown.</p><p><strong>Methods: </strong>Data from the National Health and Nutrition Examination Survey (2009-2020) were used to match GLPRA users to non-users with exact matching. Dietary patterns were identified using principal component analysis.</p><p><strong>Results: </strong>The four dietary patterns were \"Standard American\", \"Legume-Heavy\", \"Animal Protein and Vegetable\", and \"Whole Food Carbohydrate\". In a multinomial logit model among matched cases (<i>n</i> = 127) and comparisons (<i>n</i> = 1264), taking a GLPRA (vs. not) was associated with lower alignment with the Legume-Heavy pattern (0.15 vs. 0.24, <i>p</i> = 0.01), but no difference for Standard American (0.29 vs. 0.29, <i>p</i> = 0.97), Animal Protein and Vegetable (0.30 vs. 0.22, <i>p</i> = 0.07), or Whole Food Carbohydrate patterns (0.26 vs. 0.25, <i>p</i> = 0.87). There was no difference in dietary quality based on taking or not taking GLPRAs (mean Healthy Eating Index 53.7 (12.1) versus 52.6 (12.3), <i>p</i> = 0.09).</p><p><strong>Conclusion: </strong>GLPRAs were associated with lower likelihood of legume-focused dietary pattern and no difference in dietary healthfulness. Without simultaneous improvement in dietary healthfulness, there is a risk of a missed opportunity to promote healthy dietary habits among those taking GLPRAs.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":"11 3","pages":"e70079"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181988/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Science & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/osp4.70079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Mechanisms by which glucagon-like peptide receptor agonists (GLPRAs) improve cardiovascular outcomes remain incompletely understood. Whether taking GLPRAs are associated with differential dietary patterns remains unknown.
Methods: Data from the National Health and Nutrition Examination Survey (2009-2020) were used to match GLPRA users to non-users with exact matching. Dietary patterns were identified using principal component analysis.
Results: The four dietary patterns were "Standard American", "Legume-Heavy", "Animal Protein and Vegetable", and "Whole Food Carbohydrate". In a multinomial logit model among matched cases (n = 127) and comparisons (n = 1264), taking a GLPRA (vs. not) was associated with lower alignment with the Legume-Heavy pattern (0.15 vs. 0.24, p = 0.01), but no difference for Standard American (0.29 vs. 0.29, p = 0.97), Animal Protein and Vegetable (0.30 vs. 0.22, p = 0.07), or Whole Food Carbohydrate patterns (0.26 vs. 0.25, p = 0.87). There was no difference in dietary quality based on taking or not taking GLPRAs (mean Healthy Eating Index 53.7 (12.1) versus 52.6 (12.3), p = 0.09).
Conclusion: GLPRAs were associated with lower likelihood of legume-focused dietary pattern and no difference in dietary healthfulness. Without simultaneous improvement in dietary healthfulness, there is a risk of a missed opportunity to promote healthy dietary habits among those taking GLPRAs.
背景:胰高血糖素样肽受体激动剂(GLPRAs)改善心血管预后的机制尚不完全清楚。服用GLPRAs是否与不同的饮食模式有关尚不清楚。方法:采用2009-2020年全国健康与营养调查数据,对GLPRA使用者与非使用者进行精确匹配。采用主成分分析确定饮食模式。结果:四种饮食模式分别为“标准美式”、“豆类为主”、“动物蛋白+蔬菜”和“全食物碳水化合物”。在匹配病例(n = 127)和比较(n = 1264)的多项logit模型中,服用GLPRA(与不服用GLPRA)与豆类-重模式(0.15 vs. 0.24, p = 0.01)的一致性较低相关,但对于标准美式(0.29 vs. 0.29, p = 0.97)、动物蛋白和蔬菜(0.30 vs. 0.22, p = 0.07)或全食物碳水化合物模式(0.26 vs. 0.25, p = 0.87)没有差异。服用或不服用GLPRAs的饮食质量没有差异(平均健康饮食指数53.7(12.1)对52.6 (12.3),p = 0.09)。结论:GLPRAs与以豆类为主的饮食模式的可能性较低有关,在饮食健康方面没有差异。如果不同时改善饮食健康,就有可能错过在服用glpra的人群中促进健康饮食习惯的机会。